Leading Center in the Management of Esophageal and Gastric Disorders
News //

Popular heartburn drugs linked to higher early death risk

July 5th 2017

Millions of U.S. residents take proton pump inhibitors which are widely prescribed to treat heartburn, ulcers and other gastrointestinal problems. Now, a new study shows that long-term use of the popular drugs carries an increased risk of death.

Robotic Reoperative Anti-reflux Surgery: Low Perioperative Morbidity and High Symptom Resolution.

July 2018

Our group published data on re-operative surgery and showed high success rates and avoided open surgery when patients presented after a failed initial surgery. Most patients underwent their first procedure elsewhere and had excellent outcomes and low complication rates.

Heller Myotomy Versus Endoscopic Myotomy reflux outcomes

May 2017

Endoscopic POEM myotomy associated with a significantly higher reflux rate (47%) versus laparoscopic heller myotomy (11%) as well as longer hospitalization going against a less invasive approach.

Our Innovative Approach to Reflux and Achalasia

We believe that all patients have diseases that require individualized therapies with your goals as our main priority.


By achieving these goals we will aim to improve your overall quality of life.

Comprehensive Care for the Whole You

A combination of gastroenterologists, surgeons, an nutrition consultants will discuss available options for you. The team will focus on qualities and outcomes that are important to you so we can provide individualized treatment plans. 

At Weill Cornell we aim to make your treatment our priority. In most cases we can coordinate same day or next day testing at a variety of facilities including:

1. Radiology

2. High Resolution Esophageal Manometry and Endoflip

3. pH Testing

Disease Management